CSF1R and pancreatitis: Antagonists of colony-stimulating factor 1 receptor (CSF1R) or of the chemokine receptor CCR2 substantially decreased the tumor-initiating properties of CSCs in pancreatic mouse tumor models (Mitchem et al. 2013).